Latest News and Press Releases

REYKJAVIK, Iceland, June 02, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar...

REYKJAVIK, ICELAND (June 2, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for...

REYKJAVÍK 2. JÚNÍ 2026  – Alvotech tekur þátt í þremur fjárfestaráðstefnum í Bandaríkjunum fyrri hluta júnímánaðar. Þar munu Róbert Wessman, stjórnarformaður Alvotech og Balaji V. Prasad,...

REYKJAVIK, ICELAND (June 1, 2026) — Alvotech (Nasdaq: ALVO) and Islandsbanki have renewed and amended their existing market making agreement. According to the agreement, Islandsbanki places bids and...

REYKJAVÍK (1. júní 2026) — Alvotech (NASDAQ: ALVO) og Íslandsbanki hf. hafa endurnýjað og gert breytingar á samningi um viðskiptavakt á hlutabréfum Alvotech sem skráð eru á hlutabréfamarkaði Nasdaq...

- Company remains on track for BLA resubmissions in the second quarter REYKJAVIK, Iceland, May 11, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company...

Company remains on track for BLA resubmissions in the second quarter REYKJAVIK, ICELAND – May 11, 2026 – Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the...

Félagið gerir ráð fyrir að senda umsóknir um markaðsleyfi í Bandaríkjunum fyrir nýjar hliðstæður inn að nýju á öðrum ársfjórðungi REYKJAVÍK 11. MAÍ 2026 – Matvæla- og lyfjaeftirlit Bandaríkjanna...

REYKJAVIK, Iceland, May 06, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ US: ALVO, ICELAND: ALVO, STOCKHOLM: ALVO SDB) Financial Highlights  A supplemental long‑form earnings release providing...

Alvotech (NASDAQ US: ALVO, ICELAND: ALVO, STOCKHOLM: ALVO SDB) Financial Highlights  A supplemental long‑form earnings release providing additional operational details and business update for Q1...